Skip to content

Daily ideas

Latest notes
Company Deep Dive · Oct 1
[BMY] Bristol Myers Squibb: Q3 2026 earnings preview, Eliquis net price and cash flow

Bristol Myers Squibb grew Q2 2026 revenue 6% to $13.0 billion as Eliquis rose 22%; Q3 tests whether that pace and cash flow hold before Eliquis loses EU exclusivity.

Company Deep Dive · Oct 1
[PSX] Phillips 66: Q3 2026 earnings preview, refining margin capture vs. crack spreads

Phillips 66 earned $3.79 billion adjusted in Q2 2026 on a $24.08/bbl refining margin; Q3 results test how much holds once doubled crack spreads and hedge gains fade.

Company Deep Dive · Oct 1
[NET] Cloudflare: Q3 2026 Earnings Test for Pool-of-Funds Revenue and Margins

Cloudflare grew Q2 2026 revenue 36% to $696.1 million with a 73.1% non-GAAP gross margin; Q3 tests whether early pool consumption drove the beat.

Company Deep Dive · Oct 1
[ADP] ADP: Q1 Fiscal 2027 Earnings Hinge on Payroll Headcount and Float

ADP grew fiscal 2026 revenue 7% to $21.95 billion as client fund interest rose 13.9%; Q1 must show whether 1% headcount growth still supports 5%-6% Employer Services growth.

Company Deep Dive · Oct 1
[BUD] AB InBev: Q3 2026 earnings preview, cost relief vs. World Cup marketing

AB InBev grew Q2 2026 revenue 5.6% organically to $16.66 billion with EBITDA up 5.8%; Q3 tests whether easing cost pressure outweighs World Cup marketing spend.

Company Deep Dive · Oct 1
[BBVA] BBVA: Q3 2026 earnings preview, Mexico spreads, Turkey and buybacks

BBVA earned EUR 3,062 million in Q2 2026 with CET1 at 12.90%; Q3 results test whether Mexico loan growth still beats a peso spread down to 11.61%.

Company Deep Dive · Oct 1
[EQNR] Equinor: Q3 2026 earnings preview, Norwegian tax catch-up vs. buybacks

Equinor earned $11.48 billion adjusted operating income in Q2 2026 with net debt at 10.4%; Q3 tests whether cash still funds buybacks once Norwegian tax catches up.

Company Deep Dive · Sep 30
[ABBV] AbbVie: Q3 2026 Earnings Preview, Can Skyrizi Hold Its $21.7 Billion Pace?

AbbVie grew Q2 2026 revenue 10.2% to $16.99 billion as Skyrizi and Rinvoq offset Humira; Q3 results on 2026-10-30 test whether Skyrizi keeps its $21.7 billion full-year pace.

Company Deep Dive · Sep 30
[BKNG] Booking Holdings: Q3 2026 Earnings and the Long-Haul Drag on Room Nights

Booking Holdings grew Q2 2026 room nights 5.3% and revenue 8.1% to $7.35 billion; its Q3 report tests whether 3%-5% room-night guidance holds as long-haul travel stays weak.

Company Deep Dive · Sep 30
[BA] Boeing: Q3 2026 earnings preview, can the 737 ramp carry cash flow?

Boeing delivered 171 jets in Q2 2026 and turned free cash flow to $631 million; Q3 tests whether the 737 ramp to 47 a month keeps deliveries and cash positive.

Company Deep Dive · Sep 30
[AZN] AstraZeneca: Q3 2026 Earnings Preview, Can Oncology Offset Farxiga Generics?

AstraZeneca's Q2 2026 revenue rose 5% at CER to $15.38 billion with a 34% core operating margin; Q3 results test whether oncology growth can offset Farxiga generics.

Company Deep Dive · Sep 30
[WDC] Western Digital: Q1 fiscal 2027 earnings preview, HDD pricing vs. exabyte growth

Western Digital grew Q4 revenue 44% to $3.75 billion as exabytes rose only 22%; Q1 fiscal 2027 results test whether volume and 40TB costs can take over from contract pricing.

Company Deep Dive · Sep 30
[XOM] ExxonMobil: Q3 2026 earnings preview, fewer Guyana barrels vs. cash for buybacks

ExxonMobil earned $14.7 billion adjusted with $17.2 billion free cash flow in Q2 2026; Q3 tests whether fewer Guyana barrels and easing margins still fund buybacks.

Company Deep Dive · Sep 30
[CVX] Chevron: Q3 2026 earnings preview, can output growth offset lower oil?

Chevron earned $12.1 billion in Q2 2026 on $104 Brent and 20% output growth; Q3 tests whether Hess volumes and cost cuts hold upstream profit as oil and timing gains fade.

Company Deep Dive · Sep 30
[UBS] UBS: Q3 2026 earnings preview, Swiss capital rules vs. buybacks

UBS posted a 70.0% underlying cost/income ratio and 14.4% CET1 ratio in Q2 2026; Q3 results test whether buybacks hold after tougher Swiss capital rules.

Company Deep Dive · Sep 30
[CB] Chubb: Q3 2026 Earnings Preview on Casualty Margins in a Soft Market

Chubb earned $7.26 core EPS in Q2 2026 with an 83.8% P&C combined ratio; Q3 results on Oct 27 test whether casualty margins hold as soft pricing spreads.

Company Deep Dive · Sep 30
[LIN] Linde: Q3 2026 Earnings Preview, Home Care Margin Drag vs. Project Start-ups

Linde grew Q2 2026 sales 9% to $9.29 billion while its adjusted margin slipped to 29.5%; Q3 earnings test whether Americas margins recover and start-ups keep volumes growing.

Company Deep Dive · Sep 29
[AMZN] Amazon: Q3 2026 earnings preview, can AWS growth outrun AI capex?

Amazon grew Q2 2026 sales 20% to $200.6 billion as AWS rose 37%, but trailing free cash flow hit -$7.6 billion; Q3 tests whether AWS growth outruns AI capex.

Company Deep Dive · Sep 29
[TMUS] T-Mobile: Q3 2026 Earnings Preview on Churn, ARPA and Cash Flow

T-Mobile grew Q2 2026 service revenue 8.9% to $18.98 billion as account churn rose to 0.99%; Q3 results test whether higher ARPA outweighs migration-driven churn.

Company Deep Dive · Sep 29
[GILD] Gilead: Q3 2026 Earnings Test HIV Growth After the Q2 Stocking Boost

Gilead's Q2 2026 HIV sales rose 12% to $5.69 billion on higher prices and wholesaler stocking; its Q3 earnings test whether Biktarvy and Yeztugo growth holds without that lift.

121–140 of 321 · Load more
HomeDaily ideas